Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference27 articles.
1. Gross, T. (2018). Patient- vs physician-reported implementation of and compliance to anti-osteoporotic medication one year after sustained fragility fracture. Praxis (Bern 1994), 107(11), 573–584.
2. Sugiyama, T. (2018). Observational studies investigating hip fracture risk: A fundamental methodological issue? Journal of Internal Medicine, 284(3), 325–326.
3. Xie, W. P., Zhang, Y. K., Chen, Y. H., Wang, S. L., Xu, H. H., & Bi, R. X. (2018). A novel surgical method for treating medial-end clavicle fractures. Experimental and Therapeutic Medicine, 16(6), 5390–5393.
4. Rommens, P. M., Wagner, D., & Hofmann, A. (2017). Minimal invasive surgical treatment of fragility fractures of the pelvis. Chirurgia (Bucur), 112(5), 524–537.
5. Herrmann, M., Stanic, B., Hildebrand, M., Alini, M., & Verrier, S. (2019). In vitro simulation of the early pro-inflammatory phase in fracture healing reveals strong immunomodulatory effects of CD146-positive mesenchymal stromal cells. Journal of Tissue Engineering and Regenerative Medicine, 13, 1466.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献